Wanxiangfu Tang

614 total citations
21 papers, 228 citations indexed

About

Wanxiangfu Tang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wanxiangfu Tang has authored 21 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wanxiangfu Tang's work include Cancer Genomics and Diagnostics (10 papers), Chromosomal and Genetic Variations (5 papers) and Genomics and Phylogenetic Studies (5 papers). Wanxiangfu Tang is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Chromosomal and Genetic Variations (5 papers) and Genomics and Phylogenetic Studies (5 papers). Wanxiangfu Tang collaborates with scholars based in China, Canada and South Korea. Wanxiangfu Tang's co-authors include Ping Liang, Kyudong Han, Seyoung Mun, Yang Shao, Aditya Joshi, Hua Bao, Xue Wu, Yu‐Lin Wei, Rui Liu and Zheng Wang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Wanxiangfu Tang

21 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanxiangfu Tang China 7 133 77 65 51 34 21 228
Yun Ma China 9 157 1.2× 134 1.7× 40 0.6× 23 0.5× 23 0.7× 14 237
Jessica M. Grindheim United States 6 175 1.3× 58 0.8× 39 0.6× 78 1.5× 58 1.7× 10 298
Yuqian Zhou China 8 118 0.9× 76 1.0× 27 0.4× 42 0.8× 74 2.2× 37 271
Erik A. M. Jansen Netherlands 8 72 0.5× 49 0.6× 55 0.8× 70 1.4× 49 1.4× 11 189
Angela Yu United States 6 286 2.2× 197 2.6× 17 0.3× 71 1.4× 18 0.5× 6 366
Agnese Collino Italy 5 61 0.5× 36 0.5× 23 0.4× 37 0.7× 7 0.2× 5 136
Melinda Garcia United States 4 166 1.2× 86 1.1× 6 0.1× 55 1.1× 94 2.8× 5 239
Misti McCain United Kingdom 6 101 0.8× 54 0.7× 9 0.1× 49 1.0× 13 0.4× 9 205
Chaoyi Yuan China 7 138 1.0× 63 0.8× 6 0.1× 69 1.4× 47 1.4× 12 247

Countries citing papers authored by Wanxiangfu Tang

Since Specialization
Citations

This map shows the geographic impact of Wanxiangfu Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanxiangfu Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanxiangfu Tang more than expected).

Fields of papers citing papers by Wanxiangfu Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanxiangfu Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanxiangfu Tang. The network helps show where Wanxiangfu Tang may publish in the future.

Co-authorship network of co-authors of Wanxiangfu Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Wanxiangfu Tang. A scholar is included among the top collaborators of Wanxiangfu Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanxiangfu Tang. Wanxiangfu Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Qing, Hui Zhou, Wen-Kai Weng, et al.. (2025). Early detection, clinicopathological subtyping, and prognosis prediction for endometrial cancer patients using fragmentomics liquid biopsy assay. ESMO Open. 10(10). 105770–105770. 1 indexed citations
2.
Yu, Bentong, Tao Huang, Zhenhua Zhou, et al.. (2025). Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay. ESMO Open. 10(7). 105323–105323. 1 indexed citations
3.
Wu, Yuqi, Canjun Li, Yin Yang, et al.. (2024). Predicting Disease Progression in Inoperable Localized NSCLC Patients Using ctDNA Machine Learning Model. Cancer Medicine. 13(20). e70316–e70316. 4 indexed citations
4.
Zhou, Hui, et al.. (2024). Early detection, clinicopathological subtyping and prognosis prediction for patients with endometrial cancer using fragmentoimcs-based liquid-biopsy assay.. Journal of Clinical Oncology. 42(16_suppl). e17584–e17584. 1 indexed citations
5.
Han, Lu, et al.. (2024). Comprehensive characterization of PKHD1 mutation in human colon cancer. Cancer Medicine. 13(1). e6796–e6796. 1 indexed citations
6.
Bao, Hua, Xiaoxi Chen, Min Wu, et al.. (2024). Abstract 1266: Development and performance of a multi-cancer early detection test utilizing plasma cfDNA fragmentomics: A large-scale, prospective, multicenter study. Cancer Research. 84(6_Supplement). 1266–1266. 1 indexed citations
7.
Tang, Wanxiangfu, Hua Bao, Jia‐Yi Wang, et al.. (2024). Detecting pulmonary malignancy against benign nodules using noninvasive cell-free DNA fragmentomics assay. ESMO Open. 9(8). 103595–103595. 5 indexed citations
8.
Bao, Hua, Xiaoxi Chen, Min Wu, et al.. (2024). Abstract 1263: Interim results from a large-scale, prospective cohort study (JINLING) for multi-cancer early detection test in average-risk asymptomatic patients. Cancer Research. 84(6_Supplement). 1263–1263. 2 indexed citations
9.
Wang, Siwei, Jing You, Peng Chen, et al.. (2023). Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics. Cancer Research Communications. 3(5). 933–942. 12 indexed citations
10.
Li, Chong, Sisi Liu, Wanxiangfu Tang, et al.. (2022). Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. Journal of Oncology. 2022. 1–10. 3 indexed citations
11.
Yin, Rong, Siwei Wang, Ming Li, et al.. (2022). Utilization of cell-free DNA fragmentomics in minimal residual disease detection for non-small cell lung cancer.. Journal of Clinical Oncology. 40(16_suppl). 3038–3038. 2 indexed citations
12.
Zhang, Xiangyu, Zheng Wang, Wanxiangfu Tang, et al.. (2021). Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics. Hepatology. 76(2). 317–329. 54 indexed citations
13.
Li, Weihua, Lei Guo, Wanxiangfu Tang, et al.. (2021). Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer. Clinical Epigenetics. 13(1). 126–126. 19 indexed citations
14.
Jeon, Soyeon, et al.. (2021). A comprehensive analysis of gorilla-specific LINE-1 retrotransposons. Genes & Genomics. 43(10). 1133–1141. 4 indexed citations
15.
Hwang, Sung-Yeon, Hyunchul Jung, Seyoung Mun, et al.. (2021). L1 retrotransposons exploit RNA m6A modification as an evolutionary driving force. Nature Communications. 12(1). 880–880. 41 indexed citations
16.
Ma, Yuxiang, Xi Chen, Ao Wang, et al.. (2021). Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 9(3). e002014–e002014. 19 indexed citations
17.
Tang, Wanxiangfu & Ping Liang. (2020). Alu master copies serve as the drivers of differential SINE transposition in recent primate genomes. Analytical Biochemistry. 606. 113825–113825. 1 indexed citations
18.
Tang, Wanxiangfu & Ping Liang. (2019). Comparative Genomics Analysis Reveals High Levels of Differential Retrotransposition among Primates from the Hominidae and the Cercopithecidae Families. Genome Biology and Evolution. 11(11). 3309–3325. 10 indexed citations
19.
Lee, Sunyoung, Wanxiangfu Tang, Ping Liang, & Kyudong Han. (2019). A comprehensive analysis of chimpanzee (Pan troglodytes)-specific LINE-1 retrotransposons. Gene. 693. 46–51. 4 indexed citations
20.
Tang, Wanxiangfu, Seyoung Mun, Aditya Joshi, Kyudong Han, & Ping Liang. (2018). Mobile elements contribute to the uniqueness of human genome with 15,000 human-specific insertions and 14 Mbp sequence increase. DNA Research. 25(5). 521–533. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun Ma Breakdown of academic impact, for papers by Jessica M. Grindheim Breakdown of academic impact, for papers by Yuqian Zhou Breakdown of academic impact, for papers by Erik A. M. Jansen Breakdown of academic impact, for papers by Angela Yu Breakdown of academic impact, for papers by Agnese Collino Breakdown of academic impact, for papers by Melinda Garcia Breakdown of academic impact, for papers by Misti McCain Breakdown of academic impact, for papers by Chaoyi Yuan
Rankless by CCL
2026